David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Donegal Group Class A
DGICA
$710M
| $868K | ﹤0.01% |
44,194
-1,284
| -3% | -$20.9K |
|
3052
HighPeak Energy
HPK
$995M
| $867K | ﹤0.01% |
68,494
+17,052
| +33% | +$229K |
|
3053
Entravision Communication
EVC
$752M
| $864K | ﹤0.01% |
411,327
-42,254
| -9% | -$92.4K |
|
3054
Immunovant
IMVT
$8.99B
| $864K | ﹤0.01% |
50,534
-17,135
| -25% | -$358K |
|
3055
Wave Life Sciences
WVE
$1.03B
| $861K | ﹤0.01% |
106,554
-609,699
| -85% | -$6.67M |
|
3056
PUT
StoneCo
STNE
$2.26B
| $860K | ﹤0.01% |
82,100
-382,700
| -82% | -$3.61M |
|
3057
Hanover Insurance
THG
$7.91B
| $860K | ﹤0.01% |
+4,946
| New | +$801K |
|
3058
CALL
DuPont de Nemours
DD
$18.4B
| $859K | ﹤0.01% |
9,162
+6,772
| +283% | +$661K |
|
|
RDFN
3059
CALL
DELISTED
Redfin
RDFN
| $858K | ﹤0.01% |
93,200
+22,500
| +32% | +$192K |
|
3060
iShares MSCI Japan Small-Cap ETF
SCJ
$262M
| $857K | ﹤0.01% |
11,169
| – | – |
|
3061
Adeia
ADEA
$2.99B
| $855K | ﹤0.01% |
+64,704
| New | +$901K |
|
|
UCB
3062
United Community Banks
UCB
$4.23B
| $855K | ﹤0.01% |
+30,391
| New | +$951K |
|
3063
Orthofix Medical
OFIX
$393M
| $854K | ﹤0.01% |
52,380
+6,221
| +13% | +$109K |
|
3064
Nicolet Bankshares
NIC
$3.59B
| $851K | ﹤0.01% |
7,810
+4,149
| +113% | +$466K |
|
3065
Rivian
RIVN
$24.2B
| $850K | ﹤0.01% |
+68,246
| New | +$859K |
|
|
AVDX
3066
DELISTED
AvidXchange
AVDX
| $848K | ﹤0.01% |
+100,037
| New | +$925K |
|
3067
Invesco S&P 500 Revenue ETF
RWL
$10B
| $848K | ﹤0.01% |
8,535
| – | – |
|
3068
Artisan Partners
APAM
$3.1B
| $847K | ﹤0.01% |
+21,675
| New | +$918K |
|
3069
Gladstone Investment Corp
GAIN
$657M
| $847K | ﹤0.01% |
63,412
+45,778
| +260% | +$614K |
|
3070
Amphastar Pharmaceuticals
AMPH
$935M
| $846K | ﹤0.01% |
29,188
-89,663
| -75% | -$2.86M |
|
3071
Southwest Airlines
LUV
$20B
| $845K | ﹤0.01% |
25,163
+16,090
| +177% | +$510K |
|
3072
DT Midstream
DTM
$12.9B
| $842K | ﹤0.01% |
+8,731
| New | +$874K |
|
3073
Ingevity
NGVT
$2.37B
| $838K | ﹤0.01% |
21,167
-7,983
| -27% | -$353K |
|
3074
CALL
Vital Farms
VITL
$477M
| $838K | ﹤0.01% |
27,500
+13,700
| +99% | +$493K |
|
3075
Takeda Pharmaceutical
TAK
$58.6B
| $833K | ﹤0.01% |
+56,036
| New | +$785K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.